Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-18-002573
Filing Date
2018-03-20
Accepted
2018-03-20 14:17:02
Documents
1
Period of Report
2018-03-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT p7845629.html 3  
1 OWNERSHIP DOCUMENT p7845629.xml 3 4002
  Complete submission text file 0000919574-18-002573.txt   6068
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Issuer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET FLOOR 16 NEW YORK NY 10004
Business Address 250 WEST 55TH STREET FLOOR 16 NEW YORK NY 10004 212-915-2565
LIFESCI INDEX PARTNERS LLC (Reporting) CIK: 0001734312 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36620 | Film No.: 18701519

Mailing Address LIFESCI INDEX PARTNERS, LLC 250 WEST 55TH STREET, FLOOR 16 NEW YORK NY 10019
Business Address
YOOK PAUL (Reporting) CIK: 0001735029 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36620 | Film No.: 18701520